Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors

Clinical Cancer Research

Volumn 10, Issue 16, 2004, Pages 5622-5629

  Mukherjee, Purna ^a   Abate, Laura E ^a   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SOMATOMEDIN C; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CALORIC RESTRICTION; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; EPENDYMOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; MICROVASCULATURE; MOUSE; MOUSE STRAIN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCID MOUSE; TUMOR MODEL; TUMOR VASCULARIZATION;

ANIMALS; APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; DIET, REDUCING; DISEASE MODELS, ANIMAL; GLIOMA; HUMANS; MICE; MICE, INBRED C57BL; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC;

EID: 4143146391     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0308     Document Type: Article

References (53)

1. Tannenbaum A. Nutrition and cancer. In: Homburger F, editor. Physiopathology of cancer. New York: Paul B. Hober; 1959. p. 517-62.
2. Mukherjee P, Sotnikov AV, Mangian HJ, et al. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst (Bethesda) 1999;91:512-23.
3. Tannenbaum A. The genesis and growth of tumors. II. Effects of caloric restriction per se. Cancer Res 1942;2:460-7.
4. Weindruch R, Walford RL. The retardation of aging and disease by dietary restriction. Springfield, IL: Thomas; 1988.
5. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Toxicol Sci 1999;52(Suppl):13-6.
6. Rous P. The influence of diet on transplanted and spontaneous mouse tumors. J Exp Med 1914;20:433-51.
7. Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br J Cancer 2003;89:1375-82.
8. Keenan KP, Ballam GC, Soper KA, et al. Diet, caloric restriction, and the rodent bioassay. Toxicol Sci 1999;52(Suppl):24-34.
9. Jiang Z, Zheng X, Rich KM. Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death. J Neurochem 2003;84:273-81.
10. Bello L, Lucini V, Carrabba G, et al. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 2001;61: 8730-6.
11. Cheng SY, Huang HJ, Nagane M, et al. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 1996;93:8502-7.
12. Christov C, Adle-Biassette H, Le Guerinel C, Natchev S, Gherardi RK. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas. Neuropathol Appl Neurobiol 1998;24:29-35.
13. Chaudhry IH, O'Donovan DG, Brenchley PE, Reid H, Roberts IS. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 2001;39:409-15.
14. Berkman RA, Merrill MJ, Reinhold WC, et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Investig 1993;91:153-9.
15. Samoto K, Ikezaki K, Ono M, et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 1995;55:1189-93.
16. Takano S, Yoshii Y, Kondo S, et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 1996;56:2185-90.
17. Plate KH, Breier G, Millauer B, Ullrich A, Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993;53:5822-7.
18. Hirano H, Lopes MB, Laws ER Jr, et al. Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro-oncol 1999;1: 109-19.
19. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst (Bethesda) 2000;92:1472-89.
20. Kari FW, Dunn SE, French JE, Barrett JC. Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction. J Nutr Health Aging 1999;3:92-101.
21. Thornberry NA, Lazebnik Y, Caspases: enemies within, Science (Wash DC) 1998;281:1312-6.
22. Schiffer D, Fiano V, Chiado-Piat L, et al. Distribution of activated caspase-3 in relation with apoptosis in human malignant gliomas. Neurosci Lett 2001;300:37-40.
23. Xerri L, Palmerini F, Devilard E, et al. Frequent nuclear localization of ICAD and cytoplasmic co-expression of caspase-8 and caspase-3 in human lymphomas. J Pathol 2000;192:194-202,
24. Ray SK, Patel SJ, Welsh CT, et al. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. J Neurosci Res 2002;69: 197-206.
25. Boulares AH, Yakovlev AG, Ivanova V, et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 1999;274:22932-40.
26. Aft RL, Zhang FW, Gius D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer 2002; 87:805-12.
27. Ecsedy JA, Yohe HC, Bergeron AJ, Seyfried TN. Tumor-infiltrating macrophages contribute to the glycosphinglipid composition of brain tumors. J Lipid Res 1998;39:2218-27.
28. Seyfried TN, El-Abbadi M, Roy ML. Ganglioside distribution in murine neural tumors. Mol Chem Neuropathol 1992;17:147-67.
29. Ranes MK, El-Abbadi M, Manfredi MG, et al. N-butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer 2001;84:1107-14.
30. Seyfried TN, El-Abbadi M, Ecsedy JA, Bai HW, Yohe H. Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J Neurochem 1996;66:2026-33.
31. Ecsedy JA, Holthaus KA, Yohe HC, Seyfried TN. Expression of mouse sialic acid on gangliosides of a human glioma grown as a xenograft in SCID mice. J Neurochem 1999;73:254-9.
32. Flavin HJ, Wieraszko A, Seyfried TN. Enhanced aspartate release from hippocampal slices of epileptic (El) mice. J Neurochem 1991;56: 1007-11.
33. Zimmerman HM, Arnold H. Experimental brain tumors. I. Tumors produced with methylcholanthrene. Cancer Res 1941;1:919-38.
34. Rubin R, Ames RP, Sutton CH, Zimmerman HM. Virus-like particles in murine ependymoblastoma. J Neuropathol Exp Neurol 1969; 28:371-87.
35. Bai H, Seyfried TN. Influence of ganglioside GM3 and high density lipoprotein (HDL) on the cohesion of mouse brain tumor cells. J Lipid Res 1997;38:160-72.
36. Seyfried TN, Yu RK, Saito M, Albert M. Ganglioside composition of an experimental mouse brain tumor. Cancer Res 1987;47:3538-42.
37. Cotterchio M, Seyfried TN. The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors. Mol Chem Neuropathol 1993;20:163-72.
38. Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer 2002;86:1615-21.
39. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
40. Fisher LD, van Belle G. Biostatics: a methodology for the health sciences, 1st ed. New York: Wiley; 1993.
41. Streiner DL. Maintaining standards: differences between the standard deviation and standard error, and when to use each. Can J Psychiatry 1996;41:498-502.
42. Hoag WG, Dickie MM. Nutrition. In: Green EL, editor. Biology of the laboratory mouse, 2nd ed. New York: Dover; 1968.
43. Greene AE, Todorova MT, McGowan R, Seyfried TN. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001;42:1371-8.
44. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002;9:6-19.
45. Straus DS, Takemoto CD. Specific decrease in liver insulin-like growth factor-I and brain insulin-like growth factor-II gene expression in energy-restricted rats. J Nutr 1991;121:1279-86.
46. Birt DF, Yaktine A, Duysen E. Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis. J Nutr 1999; 129(Suppl):571S-4S.
47. Thompson HJ, Zhu Z, Jiang W. Identification of the apoptosis activation cascade induced in mammary carcinomas by energy restriction. Cancer Res 2004;64:1541-5.
48. Vakkala M, Paakko P, Soini Y. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer 1999;81:592-9.
49. Tanaka T, Manome Y, Wen P, Kufe DW, Fine HA. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nat Med 1997;3:437-42.
50. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2:689-92.
51. Mukherjee P, Zhau J-R, Sotnikov AV, Clinton SK. Dietary and nutritional modulation of tumor angiogenesis. In: Teicher BA, editor. Antiangiogenic agents in cancer therapy. Totowa, NJ: Humana Press; 1999. p. 237-61.
52. Kerbel RS, Viloria-Petit A, Klement G, Rak J. "Accidental" antiangiogenic drugs. Anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur J Cancer 2000;36:1248-57.
53. Tisdale MJ. Cancer anorexia and cachexia. Nutrition 2001;17: 438-42.